A phase I study of biweekly combination chemotherapy with gemcitabine (GEM) and carboplatin (CBDCA) for inoperable stages IIIB and IV non-small-cell lung cancer (NSCLC)
Yukihiro Hasegawa(Tokyo Metropolitan Children's Medical Center), Kazuhiro Okumura(Tenri Hospital), Mika Kumagai(Hirosaki University), Kageaki Taima(Hirosaki University), Takeshi Morimoto(Hyogo Medical University), H. Nakagawa(Hirosaki University), Shingo Takanashi(Sendai Kousei Hospital), A. Hayashi(Hirosaki University), Koichi Okudera(Hirosaki Central Hospital)
Cited by 1
Related Papers
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome
|Journal of the American College of Cardiology|2009|359
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
|Circulation|2009|358